3 unknown, 1 completed. 4 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 3, Completed 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Cttq: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer Autologous dendritic cells pulsed with antigen - NSCLC | Phase 1 / Phase 2 | Unknown | Henan Cancer Hospital | 30 | 2019-12-01 | 2019-12-16 |
| Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 Antibody Anlotinib, pd-1 antibody - Advanced Solid Tumor | Phase 2 / Phase 3 | Unknown | Henan Cancer Hospital | 100 | 2019-04-08 | 2019-06-05 |
| Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter Trial Anlotinib - Gastrointestinal Stromal Tumors | Phase 2 | Unknown | Cttq | 60 | 2018-10-23 | 2019-09-26 |
| Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin Caspofungin - Fungal Infection | Phase 2 | Completed | Cttq | 32 | 2018-09-17 | 2021-07-07 |
Gastrointestinal Stromal Tumors (1) · Mycoses (1)
anlotinib (2) · Antigens (1) · Caspofungin (1) · pembrolizumab (1) · spartalizumab (1)
China (4)
Zibing Wang (2) · Bo Zhang (1) · HongYan Qu (1) · Jianda Hu, Ph.D (1) · XiaoFeng Sun (1) · Xin Wu (1) · Xinhua Zhang (1) · Ye Zhou (1)